Skip to main navigation Skip to search Skip to main content

SAKK 21/12: a phase II trial of transdermal CR1447 in breast cancer patients

  • Marcus Vetter
  • , Karin M Rothgiesser
  • , Qiyu Li
  • , Hanne Hawle
  • , Wolfgang Schönfeld
  • , Karin Ribi
  • , Salome Riniker
  • , Roger von Moos
  • , Andreas Trojan
  • , Elena Kralidis
  • , Mathias Fehr
  • , Andreas Müller
  • , Beat Thürlimann
  • , _ _

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)9-18
JournalEndocrine Oncology
Volume2
Issue number1
DOIs
Publication statusPublished - 1 Mar 2022
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this